Lv11
50 积分 2024-04-25 加入
Oral insulin (ORMD‐0801) in type 2 diabetes mellitus: A dose‐finding 12‐week randomized placebo‐controlled study
25天前
已完结
Safety, Pharmacokinetics, and Pharmacodynamics of Oral Insulin Administration in Healthy Subjects: A Randomized, Double‐Blind, Phase 1 Trial
25天前
已完结
Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial
1个月前
已完结
Perspectives on the Positive and Negative Syndrome Scale (PANSS): Use, misuse, drawbacks, and a new alternative for schizophrenia research
1个月前
已关闭
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
1个月前
已完结
Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials
1个月前
已完结
Efficacy and safety of betaine anhydrous in patients with homocystinuria
1个月前
已完结
Design of Clinical Trials for Mild to Moderate Ulcerative Colitis
2个月前
已完结
Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial
3个月前
已完结
Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
3个月前
已完结
皖公网安备34019202002308
